Damage associated molecular patterns within xenogeneic biologic scaffolds and their effects on host remodeling

Biomaterials

Volumn 33, Issue 1, 2012, Pages 91-101

  Daly, K A ^a   Liu, S ^b   Agrawal, V ^c   Brown, B N ^d   Johnson, S A ^c   Medberry, C J ^b   Badylak, S F ^a  

^a MCGOWAN INSTITUTE FOR REGENERATIVE MEDICINE   (United States)

^b University of Pittsburgh   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

^d Department of Obstetrics Gynecology   (United States)

Author keywords

Extracellular matrix; Immune response; Immunomodulation; Monocyte

Indexed keywords

ANTI-INFLAMMATORIES; BIOACTIVE MOLECULES; CHEMICAL CROSS-LINKING; CHEMOKINES; DECELLULARIZATION; EXTRACELLULAR MATRICES; FOREIGN BODY REACTIONS; GLYCYRRHIZIN; IDENTIFICATION AND EVALUATION; IMMUNE RESPONSE; IMMUNOMODULATION; IMMUNOMODULATORY EFFECTS; IN-VIVO; MOLECULAR PATTERNS; MONOCYTE; MRNA EXPRESSION; SIGNALING RECEPTOR; TISSUE SOURCES; TOLL-LIKE RECEPTOR 4; UP-REGULATION;

CELL DEATH; CELL PROLIFERATION; CHEMICAL MODIFICATION; CROSSLINKING; ENZYME ACTIVITY; IMMUNOLOGY; MOLECULES; TISSUE;

SCAFFOLDS (BIOLOGY);

GLYCYRRHIZIC ACID; HIGH MOBILITY GROUP B1 PROTEIN; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; TISSUE SCAFFOLD; TOLL LIKE RECEPTOR 4;

ANIMAL TISSUE; ARTICLE; CELL DEATH; CELL PROLIFERATION; CONTROLLED STUDY; CROSS LINKING; CYTOKINE RELEASE; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOMODULATION; INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; RECEPTOR UPREGULATION;

ANIMALS; BLOTTING, WESTERN; CELL LINE, TUMOR; CHEMOKINE CCL2; CHEMOKINE CCL4; ENZYME-LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR MATRIX; HMGB1 PROTEIN; HUMANS; IMMUNOMODULATION; MICE; RATS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SWINE; TISSUE ENGINEERING; TISSUE SCAFFOLDS; TOLL-LIKE RECEPTOR 4;

EID: 82855172117     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2011.09.040     Document Type: Article

References (57)

1. Brennan E.P., Reing J., Chew D., Myers-Irvin J.M., Young E.J., Badylak S.F. Antibacterial activity within degradation products of biological scaffolds composed of extracellular matrix. Tissue Eng 2006, 12:2949-2955.
2. Badylak S.F., Wu C.C., Bible M., McPherson E. Host protection against deliberate bacterial contamination of an extracellular matrix bioscaffold versus dacron mesh in a dog model of orthopedic soft tissue repair. J Biomed Mater Res B Appl Biomater 2003, 67:648-654.
3. Badylak S.F., Valentin J.E., Ravindra A.K., McCabe G.P., Stewart-Akers A.M. Macrophage phenotype as a determinant of biologic scaffold remodeling. Tissue Eng Part A 2008, 14:1835-1842.
4. Brown B.N., Valentin J.E., Stewart-Akers A.M., McCabe G.P., Badylak S.F. Macrophage phenotype and remodeling outcomes in response to biologic scaffolds with and without a cellular component. Biomaterials 2009, 30:1482-1491.
5. Valentin J.E., Stewart-Akers A.M., Gilbert T.W., Badylak S.F. Macrophage participation in the degradation and remodeling of extracellular matrix scaffolds. Tissue Eng Part A 2009, 15:1687-1694.
6. Schutte R.J., Xie L., Klitzman B., Reichert W.M. In vivo cytokine-associated responses to biomaterials. Biomaterials 2009, 30:160-168.
7. Valentin J.E., Badylak J.S., McCabe G.P., Badylak S.F. Extracellular matrix bioscaffolds for orthopaedic applications. A comparative histologic study. J Bone Jt Surg Am 2006, 88:2673-2686.
8. Gilbert T.W., Freundb S.J., Badylak S.F. Quantification of DNA in biologic scaffold materials. J Surg Res 2008.
9. Thomas J.O. HMG1 and 2: architectural DNA-binding proteins. Biochem Soc Trans 2001, 29:395-401.
10. Porto A., Palumbo R., Pieroni M., Aprigliano G., Chiesa R., Sanvito F., et al. Smooth muscle cells in human atherosclerotic plaques secrete and proliferate in response to high mobility group box 1 protein. FASEB J 2006, 20:2565-2566.
11. Andrassy M., Volz H.C., Igwe J.C., Funke B., Eichberger S.N., Kaya Z., et al. High-mobility group box-1 in ischemia-reperfusion injury of the heart. Circulation 2008, 117:3216-3226.
12. Kokkola R., Li J., Sundberg E., Aveberger A.C., Palmblad K., Yang H., et al. Successful treatment of collagen-induced arthritis in mice and rats by targeting extracellular high mobility group box chromosomal protein 1 activity. Arthritis Rheum 2003, 48:2052-2058.
13. Tian J., Avalos A.M., Mao S.Y., Chen B., Senthil K., Wu H., et al. Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE. Nat Immunol 2007, 8:487-496.
14. Zimmermann K., Volkel D., Pable S., Lindner T., Kramberger F., Bahrami S., et al. Native versus recombinant high-mobility group B1 proteins: functional activity in vitro. Inflammation 2004, 28:221-229.
15. Fiuza C., Bustin M., Talwar S., Tropea M., Gerstenberger E., Shelhamer J.H., et al. Inflammation-promoting activity of HMGB1 on human microvascular endothelial cells. Blood 2003, 101:2652-2660.
16. Lolmede K., Campana L., Vezzoli M., Bosurgi L., Tonlorenzi R., Clementi E., et al. Inflammatory and alternatively activated human macrophages attract vessel-associated stem cells, relying on separate HMGB1- and MMP-9-dependent pathways. J Leukoc Biol 2009, 85:779-787.
17. Yang D., Chen Q., Yang H., Tracey K.J., Bustin M., Oppenheim J.J. High mobility group box-1 protein induces the migration and activation of human dendritic cells and acts as an alarmin. J Leukoc Biol 2007, 81:59-66.
18. De Mori R., Straino S., Di Carlo A., Mangoni A., Pompilio G., Palumbo R., et al. Multiple effects of high mobility group box protein 1 in skeletal muscle regeneration. Arterioscler Thromb Vasc Biol 2007, 27:2377-2383.
19. Straino S., Di Carlo A., Mangoni A., De Mori R., Guerra L., Maurelli R., et al. High-mobility group box 1 protein in human and murine skin: involvement in wound healing. J Invest Dermatol 2008, 128:1545-1553.
20. Ranzato E., Patrone M., Pedrazzi M., Burlando B. HMGb1 promotes scratch wound closure of HaCaT keratinocytes via ERK1/2 activation. Mol Cell Biochem 2009, 332:199-205.
21. Limana F., Germani A., Zacheo A., Kajstura J., Di Carlo A., Borsellino G., et al. Exogenous high-mobility group box 1 protein induces myocardial regeneration after infarction via enhanced cardiac C-kit+ cell proliferation and differentiation. Circ Res 2005, 97:e73-e83.
22. Gilbert T.W., Freund J.M., Badylak S.F. Quantification of DNA in biologic scaffold materials. J Surg Res 2009, 152:135-139.
23. Schutte R.J., Parisi-Amon A., Reichert W.M. Cytokine profiling using monocytes/macrophages cultured on common biomaterials with a range of surface chemistries. J Biomed Mater Res A 2009, 88:128-139.
24. Mollica L., De Marchis F., Spitaleri A., Dallacosta C., Pennacchini D., Zamai M., et al. Glycyrrhizin binds to high-mobility group box 1 protein and inhibits its cytokine activities. Chem Biol 2007, 14:431-441.
25. Badylak S.F., Lantz G.C., Coffey A., Geddes L.A. Small intestinal submucosa as a large diameter vascular graft in the dog. J Surg Res 1989, 47:74-80.
26. Freytes D.O., Badylak S.F., Webster T.J., Geddes L.A., Rundell A.E. Biaxial strength of multilaminated extracellular matrix scaffolds. Biomaterials 2004, 25:2353-2361.
27. Reing J.E., Brown B.N., Daly K.A., Freund J.M., Gilbert T.W., Hsiong S.X., et al. The effects of processing methods upon mechanical and biologic properties of porcine dermal extracellular matrix scaffolds. Biomaterials 2010, 31:8626-8633.
28. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25:402-408.
29. Chen H., Li P., Yin Y., Cai X., Huang Z., Chen J., et al. The promotion of type 1 T helper cell responses to cationic polymers in vivo via toll-like receptor-4 mediated IL-12 secretion. Biomaterials 2010, 31:8172-8180.
30. Shokouhi B., Coban C., Hasirci V., Aydin E., Dhanasingh A., Shi N., et al. The role of multiple toll-like receptor signalling cascades on interactions between biomedical polymers and dendritic cells. Biomaterials 2010, 31:5759-5771.
31. Rogers T.H., Babensee J.E. Altered adherent leukocyte profile on biomaterials in toll-like receptor 4 deficient mice. Biomaterials 2010, 31:594-601.
32. Martinez C.O., McHale M.J., Wells J.T., Ochoa O., Michalek J.E., McManus L.M., et al. Regulation of skeletal muscle regeneration by CCR2-activating chemokines is directly related to macrophage recruitment. Am J Physiol Regul Integr Comp Physiol 2010, 299:R832-R842.
33. Yahiaoui L., Gvozdic D., Danialou G., Mack M., Petrof B.J. CC family chemokines directly regulate myoblast responses to skeletal muscle injury. J Physiol 2008, 586:3991-4004.
34. Lu H., Huang D., Ransohoff R.M., Zhou L. Acute skeletal muscle injury: CCL2 expression by both monocytes and injured muscle is required for repair. FASEB J 2011, 10.1096/fj.10-178939.
35. Lu H., Huang D., Saederup N., Charo I.F., Ransohoff R.M., Zhou L. Macrophages recruited via CCR2 produce insulin-like growth factor-1 to repair acute skeletal muscle injury. FASEB J 2011, 25:358-369.
36. Daly K.A., Stewart-Akers A.M., Hara H., Ezzelarab M., Long C., Cordero K., et al. Effect of the alphaGal epitope on the response to small intestinal submucosa extracellular matrix in a nonhuman primate model. Tissue Eng Part A 2009, 15:3877-3888.
37. Daly K.A., Wolf M.T., Johnson S.A., Badylak S.F. A rabbit model of peripheral compartment syndrome with associated rhabdomyolysis and a regenerative medicine approach for treatment. Tissue Eng Part C 2011, 17:631-640.
38. Brennan E.P., Tang X.H., Stewart-Akers A.M., Gudas L.J., Badylak S.F. Chemoattractant activity of degradation products of fetal and adult skin extracellular matrix for keratinocyte progenitor cells. J Tissue Eng Regen Med 2008, 2:491-498.
39. Brown B.N., Barnes C.A., Kasick R.T., Michel R., Gilbert T.W., Beer-Stolz D., et al. Surface characterization of extracellular matrix scaffolds. Biomaterials 2010, 31:428-437.
40. Troyano A., Sancho P., Fernandez C., de Blas E., Bernardi P., Aller P. The selection between apoptosis and necrosis is differentially regulated in hydrogen peroxide-treated and glutathione-depleted human promonocytic cells. Cell Death Differ 2003, 10:889-898.
41. Tarrab E., Huet P.M., Brault A., Rocheleau B., Laurens M., Crenesse D. Cyclosporin-A does not prevent cold ischemia/reperfusion injury of rat livers. J Surg Res 2011.
42. Brightbill H.D., Libraty D.H., Krutzik S.R., Yang R.B., Belisle J.T., Bleharski J.R., et al. Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors. Science 1999, 285:732-736.
43. Seki E., De Minicis S., Osterreicher C.H., Kluwe J., Osawa Y., Brenner D.A., et al. TLR4 enhances TGF-beta signaling and hepatic fibrosis. Nat Med 2007, 13:1324-1332.
44. Konishi H., Nakatsuka M., Chekir C., Noguchi S., Kamada Y., Sasaki A., et al. Advanced glycation end products induce secretion of chemokines and apoptosis in human first trimester trophoblasts. Hum Reprod 2004, 19:2156-2162.
45. Wang S., Schmaderer C., Kiss E., Schmidt C., Bonrouhi M., Porubsky S., et al. Recipient toll-like receptors contribute to chronic graft dysfunction by both MyD88- and TRIF-dependent signaling. Dis Model Mech 2010, 3:92-103.
46. Isoda K., Folco E., Marwali M.R., Ohsuzu F., Libby P. Glycated LDL increases monocyte CC chemokine receptor 2 expression and monocyte chemoattractant protein-1-mediated chemotaxis. Atherosclerosis 2008, 198:307-312.
47. Sabbatucci M., Purificato C., Fantuzzi L., Gessani S. Toll-like receptor cross-talk in human monocytes regulates CC-chemokine production, antigen uptake and immune cell recruitment. Immunobiology 2011.
48. Choi J., Lee M.K., Oh K.H., Kim Y.S., Choi H.Y., Baek S.K., et al. Interaction effect between the receptor for advanced glycation end products (RAGE) and high-mobility group box-1 (HMGB-1) for the migration of a squamous cell carcinoma cell line. Tumori 2011, 97:196-202.
49. Hoffmann K.F., McCarty T.C., Segal D.H., Chiaramonte M., Hesse M., Davis E.M., et al. Disease fingerprinting with cDNA microarrays reveals distinct gene expression profiles in lethal type 1 and type 2 cytokine-mediated inflammatory reactions. FASEB J 2001, 15:2545-2547.
50. Chow F.Y., Nikolic-Paterson D.J., Ma F.Y., Ozols E., Rollins B.J., Tesch G.H. Monocyte chemoattractant protein-1-induced tissue inflammation is critical for the development of renal injury but not type 2 diabetes in obese db/db mice. Diabetologia 2007, 50:471-480.
51. Kitagawa K., Wada T., Furuichi K., Hashimoto H., Ishiwata Y., Asano M., et al. Blockade of CCR2 ameliorates progressive fibrosis in kidney. Am J Pathol 2004, 165:237-246.
52. Biswas S.K., Sodhi A. In vitro activation of murine peritoneal macrophages by monocyte chemoattractant protein-1: upregulation of CD11b, production of proinflammatory cytokines, and the signal transduction pathway. J Interferon Cytokine Res 2002, 22:527-538.
53. Allman A.J., McPherson T.B., Badylak S.F., Merrill L.C., Kallakury B., Sheehan C., et al. Xenogeneic extracellular matrix grafts elicit a TH2-restricted immune response. Transplantation 2001, 71:1631-1640.
54. Ansaloni L., Cambrini P., Catena F., Di Saverio S., Gagliardi S., Gazzotti F., et al. Immune response to small intestinal submucosa (surgisis) implant in humans: preliminary observations. J Invest Surg 2007, 20:237-241.
55. Tiainen J., Soini Y., Suokas E., Veiranto M., Tormala P., Waris T., et al. Tissue reactions to bioabsorbable ciprofloxacin-releasing polylactide-polyglycolide 80/20 screws in rabbits' cranial bone. J Mater Sci Mater Med 2006, 17:1315-1322.
56. Tiainen J., Soini Y., Tormala P., Waris T., Ashammakhi N. Self-reinforced polylactide/polyglycolide 80/20 screws take more than 1(1/2) years to resorb in rabbits' cranial bone. J Biomed Mater Res B Appl Biomater 2004, 70:49-55.
57. Brodbeck W.G., Patel J., Voskerician G., Christenson E., Shive M.S., Nakayama Y., et al. Biomaterial adherent macrophage apoptosis is increased by hydrophilic and anionic substrates in vivo. Proc Natl Acad Sci U S A 2002, 99:10287-10292.